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Introduction
An increase in single occupancy rooms reduces trans-
mission, improves hand hygiene compliance and
increases patient satisfaction. Thus, there is a demand
for more single rooms, particularly in hospitals with a
low proportion of single rooms as is common in Europe.
Furthermore, where the previous room occupant was
infected or colonised with a pathogen, the subsequent
admission is significantly less likely to acquire that
pathogen if the room is decontaminated using hydrogen
peroxide vapour (HPV) rather than being cleaned and
disinfected using standard methods.
Objectives
Bioquell has developed the ‘Infection Control Enclosure’
(ICE)-pod, a bespoke, semi-permanent structure with a
door and an integral air handling system to provide a
negative air-flow, which can be erected around existing
bed spaces without closing wards.
Methods
The ICE-pod combines many of the benefits of single
rooms whilst retaining the primary advantages of bays
/open wards. The pods can also be sealed for HPV
decontamination.
Results
ICE-pods can be used to interrupt the spread of nosoco-
mial pathogens by providing additional capacity to segre-
gate patients known to be infected or colonised with
pathogens, for pre-emptive segregation of high-risk
patients, to provide a single room environment for patients
that require high visibility such as those at risk of falls, and
the ability to decontaminate individual bed spaces using
HPV. The ICE-pod will also improve the privacy and
dignity of patients cared for in multi-occupancy areas,
and has the potential to “free up” side rooms for patients
requiring additional privacy and dignity. There are tangible
potential cost-benefit advantages associated with acceler-
ated discharge from intensive care units and other
high-cost units and avoiding the high cost of permanent
conversion programs. The ICE-pod will provide an overall
improvement in the flexibility of patient flow throughout a
hospital, which will increase throughput and decrease the
number of patients placed temporarily in sub-optimal
specialties.
Conclusion
Implementation is currently underway in the UK and
will include assessment of patient and staff acceptability
of the ICE-pod. Further trials to evaluate the clinical
impact of the ICE-pod are planned.
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